QXO, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by QXO, Inc. on August 21, 2026. The filing discloses the appointment of a new senior executive officer and details the associated compensatory arrangements.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and personnel changes.
Material Changes and Executive Appointment
On August 21, 2026, QXO, Inc. announced the appointment of Ken West as President and Chief Operating Officer, effective September 1, 2026. Mr. West joins from Honeywell Technologies, where he held various senior leadership roles including CEO of Honeywell Process Technology. The filing details a comprehensive compensation package:
- Base Salary: $850,000 annually.
- Target Bonus: 125% of base salary ($1,062,500), potentially pro-rated for fiscal year 2026.
- Annual Long-Term Incentives:
- Time-based Restricted Stock Units (RSUs) with a grant-date value of $867,808, vesting over four years.
- Performance-based Restricted Stock Units (PSUs) with a grant-date value of $867,808, tied to total stockholder return relative to the S&P 500 Index through December 31, 2030.
- Equity Sign-On Award: RSUs with a grant-date value of $5,500,000, vesting 50% on the second anniversary and 50% on the fourth anniversary.
- New Hire Incentive Award: RSUs with a grant-date value of $2,500,000, vesting in full one month after the grant date. This award includes a clawback provision requiring repayment if employment terminates prior to the second anniversary of the start date (excluding involuntary termination without cause).
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of general business risks. The primary contingency noted is the clawback provision associated with the New Hire Incentive Award, which requires repayment of the fair market value of the award if Mr. West departs under specific conditions within two years of his start date.
Key Facts for Investor Verification
- Verify the total grant-date value of equity awards ($9,735,616) and the associated dilution impact on existing shareholders.
- Confirm the vesting schedules and performance metrics for the PSUs, specifically the S&P 500 relative TSR targets.
- Review the full text of the Offer Letter (to be filed as an exhibit to the Q3 2026 Form 10-Q) for additional terms regarding severance and confidentiality.
- Assess the strategic rationale for hiring an executive with a background in industrial and process technologies for QXO's specific business model.